Andrew Leuchter, MD
Enriched profileDistinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior · University of California, Los Angeles
Andrew Leuchter is Distinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles. OpenAlex indexes 281 publications with 10,920 citations (h-index 61); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 23 Oct 2026
Andrew Leuchter, MD, is Distinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles. The public record shows 281 publications with 10,920 citations (h-index 61), centered on Treatment of Major Depression, Transcranial Magnetic Stimulation Studies, Electroconvulsive Therapy Studies. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 1 companies, 10 NIH-funded awards (1986–2026).
- Most recent indexed publication: 2020 · Journal of autism and developmental disorders
- Top research focus: Treatment of Major Depression
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 158.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Treatment of Borderline Personality Disorder With rTMS
Sponsor: University of California, Los Angeles
- Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Sponsor: University of California, Los Angeles
- Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Sponsor: Abbott Medical Devices
Industry payments
Updated 23 Oct 2026
1 company reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Abbott LaboratoriesProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Mood Stabilizer30.5%Lamotrigine100%Part D<11 patientsGabapentinoids28.8%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
10 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in MDD
University of California Los Angeles
FY2026$762,933R01MH135293 - Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in MDD
University of California Los Angeles
FY2025$642,796R01MH135293 - Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in MDD
University of California Los Angeles
FY2024$738,063R01MH135293
Congress activity
Updated 23 Oct 2026
1 congress contribution (2026) across ASCO per OpenAlex. The most recent:
- Scrambler therapy for painful chemotherapy-induced peripheral neuropathy: Extending the evidence base.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex.
Journal of autism and developmental disorders
Article2020
Most-cited works
by citation count (OpenAlex)- 01
- 02Changes in Brain Function of Depressed Subjects During Treatment With PlaceboArticle396 citations2002
- 03Assessing the accuracy of topographic EEG mapping for determining local brain functionArticle297 citations1998
- 04
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/andrew-leuchter-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
uclahealth.org/providers/andrew-leuchter
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuromodulation.ucla.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
Secondary affiliations
appointments beyond the home institution- Executive Vice Chair
Department of Psychiatry and Biobehavioral Sciences, UCLA; Associate Director, Semel Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗ - Director
Neuromodulation Division (Semel Institute)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuromodulation.ucla.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →laist.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bri.ucla.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania